December 2014
What’s Inside

At AVA, Expanding Scope of Vascular Access Practice Is a Big Focus

Expanding Vascular Access Practice: Experts Tell How They Did It

JAVA Study: ARROW® PICC with Chlorag+ard® Technology Reduced Bloodstream Infections and Treatment Costs


At AVA, Expanding Scope of Vascular Access
Practice Was a Big Focus

The growing trend toward having vascular access professionals place CVCs and arterial lines was a big focus at the recent AVA annual meeting. Also, a frequent topic of discussion was the Affordable Care Act (ACA, or Obamacare) and the opportunities it’s creating for vascular access clinicians to have more influence.

The meeting officially kicked off with a rousing keynote from Matthew Ostroff, the Vascular Access Coordinator at St Joseph’s Hospital, in Emerson, N.J. Among other highlights, Nancy Moureau of PICC Excellence received the Herbst Award for excellence. And pressing issues such as superbugs and venous thrombosis were the topic of well-attended talks.
The Premier Institute’s Leslie Schultz focused her talk on how the ACA can be instrumental in expanding the role of non-physician inserters and in lowering hospital CLABSI. She discusses her key points in this video.

To read more, click here

Expanding Vascular Access Practice:
Experts Tell How They Did It

If you wanted to expand the scope of your vascular access nursing practice, how would you go about doing it? Presentations at the recent conference of the Association for Vascular Access provided tips on how clinicians can expand their roles to insert central venous and arterial catheters.

The two posters were a testament to the growing movement for nurses to expand their practices to include CVC and arterial line insertions – a movement that Teleflex supports with CVC courses and other tools.

Also talking to colleagues at AVA about expanding practices to include placement of central lines was Jim Bryant, Vascular Access Specialist, Chesapeake Regional Medical Center, Chesapeake who summarizes his experience and offers tips in this brief video.

To read more, click here

JAVA Study: ARROW® PICC with Chlorag+ard® Technology Reduced Bloodstream Infections and Treatment Costs
A new study in the AVA journal shows that a unique antimicrobial and antithrombogenic PICC was associated with a nearly nine-fold reduction in the rate of CLABSIs at a leading California hospital. Use of the ARROW® PICC with Chlorag+ard® Technology was the only intervention that a large San Diego-area medical center undertook to reduce bloodstream infections during the study period. The CLABSI reduction was statistically significant.

To read more, click here

Matthew Ostroff is a per diem and paid consultant of Teleflex Incorporated.
Leslie Schultz is a paid speaker and consultant of Teleflex Incorporated.
Jim Bryant is a paid speaker of Teleflex Incorporated.

VA-BC is a trademark of The Vascular Access Certification Corporation.
Teleflex, Arrow and Chlorag+ard are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
© 2014 Teleflex Incorporated. All rights reserved. MC-000657


TELEFLEX PO Box 12600 Research Triangle Park, NC 27709
Toll Free: 866.246.6990 Phone: +1.919.544.8000
TELEFLEX.COM